Harun Uslu

468 total citations
33 papers, 389 citations indexed

About

Harun Uslu is a scholar working on Organic Chemistry, Molecular Biology and Computational Theory and Mathematics. According to data from OpenAlex, Harun Uslu has authored 33 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Organic Chemistry, 11 papers in Molecular Biology and 8 papers in Computational Theory and Mathematics. Recurrent topics in Harun Uslu's work include Synthesis and biological activity (10 papers), Computational Drug Discovery Methods (8 papers) and Cholinesterase and Neurodegenerative Diseases (6 papers). Harun Uslu is often cited by papers focused on Synthesis and biological activity (10 papers), Computational Drug Discovery Methods (8 papers) and Cholinesterase and Neurodegenerative Diseases (6 papers). Harun Uslu collaborates with scholars based in Türkiye and United Kingdom. Harun Uslu's co-authors include Neslihan Demirbaş, Arif Mermer, A. Demirbaş, Yakup Şirin, A.B. Dempster, Zeynep Özdemir, Arzu Karakurt, Şule Ceylan, Nahit Gençer and Bülent Alıcı and has published in prestigious journals such as Life Sciences, European Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry.

In The Last Decade

Harun Uslu

30 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harun Uslu Türkiye 13 257 104 72 66 39 33 389
Jorge Soto‐Delgado Chile 13 232 0.9× 111 1.1× 45 0.6× 34 0.5× 23 0.6× 39 415
Adnan Shahzad Pakistan 10 249 1.0× 79 0.8× 45 0.6× 38 0.6× 64 1.6× 19 404
Stoyanka Nikolova Bulgaria 12 273 1.1× 111 1.1× 40 0.6× 33 0.5× 63 1.6× 48 460
O. Ozgen Türkiye 5 421 1.6× 82 0.8× 55 0.8× 77 1.2× 55 1.4× 7 506
Aziz‐ur‐Rehman Pakistan 15 294 1.1× 102 1.0× 73 1.0× 61 0.9× 32 0.8× 43 479
R. Kumaresan India 11 305 1.2× 56 0.5× 78 1.1× 35 0.5× 18 0.5× 19 456
Sarangapani Manda India 13 435 1.7× 116 1.1× 48 0.7× 44 0.7× 76 1.9× 42 539
Mymoona Akhtar India 10 471 1.8× 137 1.3× 70 1.0× 80 1.2× 93 2.4× 20 618
Burçin Türkmenoğlu Türkiye 13 340 1.3× 149 1.4× 142 2.0× 108 1.6× 91 2.3× 67 496
Sandip D. Firke India 7 237 0.9× 116 1.1× 53 0.7× 110 1.7× 24 0.6× 25 419

Countries citing papers authored by Harun Uslu

Since Specialization
Citations

This map shows the geographic impact of Harun Uslu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harun Uslu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harun Uslu more than expected).

Fields of papers citing papers by Harun Uslu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harun Uslu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harun Uslu. The network helps show where Harun Uslu may publish in the future.

Co-authorship network of co-authors of Harun Uslu

This figure shows the co-authorship network connecting the top 25 collaborators of Harun Uslu. A scholar is included among the top collaborators of Harun Uslu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harun Uslu. Harun Uslu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Uslu, Harun, Derya Osmani̇ye, Elif Öncü, et al.. (2025). Design, synthesis, and antiproliferative activity evaluation of novel cyclic secondary amine containing dithiocarbamate derivatives as potent EGFR inhibitors. Journal of Molecular Structure. 1335. 142036–142036. 3 indexed citations
2.
Gençer, Nahit, et al.. (2025). Hidden targets in dermatology: In vitro and In silico inhibitory effects of common 23 dermatologic drugs on human carbonic anhydrase isoenzymes I and II. Journal of Enzyme Inhibition and Medicinal Chemistry. 40(1). 2540935–2540935.
3.
4.
Uslu, Harun, et al.. (2025). Discovery of new anti-HIV candidate molecules with an AI-based multi-stage system approach using molecular docking and ADME predictions. Chemometrics and Intelligent Laboratory Systems. 267. 105543–105543. 1 indexed citations
5.
6.
Bingül, Murat, et al.. (2025). Shedding Light on the Phytochemical and Biological Fingerprints of Fibigia clypeata (L.) Medik Essential Oil as a Pharmacotherapeutic Agent. Food Science & Nutrition. 13(7). e70493–e70493. 1 indexed citations
7.
Uslu, Harun, et al.. (2024). Synthesis of some benzothiazole-piperazine derivatives, investigation by in vitro and molecular modelling for hMAO inhibitory activities. DergiPark (Istanbul University). 3(2). 72–81. 2 indexed citations
8.
Uslu, Harun, Derya Osmani̇ye, Serkan Levent, et al.. (2024). Synthesis of new piperazine‐oxadiazole derivatives and investigation of their anticancer activities. Journal of Molecular Structure. 1322. 140298–140298. 2 indexed citations
9.
10.
Doğan, Hacer, Suat Tekin, Harun Uslu, et al.. (2022). (E)-1-(4-Hydroxyphenyl)-3-(substituted-phenyl) prop-2-en-1-ones: Synthesis, In Vitro Cytotoxic Activity and Molecular Docking Studies. Acta chimica slovenica. 69(2). 281–292. 1 indexed citations
11.
Aslan, Abdullah Nabi, et al.. (2022). In vivo, in vitro and in silico anticancer investigation of fullerene C60 on DMBA induced breast cancer in rats. Life Sciences. 291. 120281–120281. 22 indexed citations
12.
13.
Uslu, Harun, Derya Osmani̇ye, Begüm Nurpelin Sağlık, et al.. (2021). Design, synthesis, in vitro, and in silico studies of 1,2,4-triazole-piperazine hybrid derivatives as potential MAO inhibitors. Bioorganic Chemistry. 117. 105430–105430. 9 indexed citations
14.
Özdemir, Zeynep, et al.. (2020). Synthesis, molecular modelling and biological activity of some pyridazinone derivatives as selective human monoamine oxidase-B inhibitors. Pharmacological Reports. 72(3). 692–704. 15 indexed citations
15.
Özdemir, Zeynep, et al.. (2019). A Series of New Hydrazone Derivatives: Synthesis, Molecular Docking and Anticholinesterase Activity Studies. Mini-Reviews in Medicinal Chemistry. 20(11). 1042–1060. 23 indexed citations
16.
Mermer, Arif, Neslihan Demirbaş, Yakup Şirin, et al.. (2018). Conventional and microwave prompted synthesis, antioxidant, anticholinesterase activity screening and molecular docking studies of new quinolone-triazole hybrids. Bioorganic Chemistry. 78. 236–248. 44 indexed citations
17.
Sarı, Suat, Arzu Karakurt, Harun Uslu, et al.. (2016). New (arylalkyl)azole derivatives showing anticonvulsant effects could have VGSC and/or GABA A R affinity according to molecular modeling studies. European Journal of Medicinal Chemistry. 124. 407–416. 22 indexed citations
18.
Karataş, Mert Olgun, Harun Uslu, Suat Sarı, et al.. (2015). Coumarin or benzoxazinone based novel carbonic anhydrase inhibitors: synthesis, molecular docking and anticonvulsant studies. Journal of Enzyme Inhibition and Medicinal Chemistry. 31(5). 760–772. 36 indexed citations
19.
Dempster, A.B. & Harun Uslu. (1978). Infrared spectra and stability of Hofmann-type dioxane clathrates. Spectrochimica Acta Part A Molecular Spectroscopy. 34(1). 71–75. 17 indexed citations
20.
Dempster, A.B. & Harun Uslu. (1974). Rotational isomerism in open-chain polychlorinated hydrocarbons. Journal of Molecular Structure. 21(2). 197–219. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jorge Soto‐Delgado Breakdown of academic impact, for papers by Adnan Shahzad Breakdown of academic impact, for papers by Stoyanka Nikolova Breakdown of academic impact, for papers by O. Ozgen Breakdown of academic impact, for papers by Aziz‐ur‐Rehman Breakdown of academic impact, for papers by R. Kumaresan Breakdown of academic impact, for papers by Sarangapani Manda Breakdown of academic impact, for papers by Mymoona Akhtar Breakdown of academic impact, for papers by Burçin Türkmenoğlu Breakdown of academic impact, for papers by Sandip D. Firke
Rankless by CCL
2026